Original language | English |
---|---|
Pages (from-to) | 17-17 |
Number of pages | 1 |
Journal | Neuro-Oncology |
Volume | 19 |
Publication status | Published - Nov 2017 |
Event | 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology - San Francisco, United States Duration: 16 Nov 2017 → 19 Nov 2017 |
A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)
Lawrence Cher, Anna Nowak, George Iatropoulos, Weon Sup Lee, Seon Young Lee, Sang Ryeol Shim, Jin San Yoo
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
6
Citations
(Web of Science)